Quantinno Capital Management LP

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1759654 NEW YORK, NY

Position in ALNY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,199,949

+$1,023,291 QoQ

Shares Held

33,850

+32.3% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Quantinno Capital Management LP holds $387,171,373 across 157 Biotechnology names. ALNY ranks #7 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	126,604	$56,533,750
2	TECH	BIO-TECHNE Corp	814,322	$42,556,467
3	REGN	Regeneron Pharmaceuticals, Inc.	48,251	$37,280,652
4	JAZZ	Jazz Pharmaceuticals plc	191,286	$36,162,618
5	RPRX	Royalty Pharma plc	382,571	$18,351,930
6	INCY	Incyte Corp	158,226	$14,892,231
7	ALNY	Alnylam Pharmaceuticals, Inc. This page	33,850	$11,199,949
8	HALO	Halozyme Therapeutics, Inc.	138,547	$8,954,292

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,199,949	33,850	+32.3%	Shares	Sole	2026-05-15
2025-12-31	$10,176,658	25,592	+32.8%	Shares	Sole	2026-02-17
2025-09-30	$8,784,840	19,265	+43.1%	Shares	Sole	2025-11-14
2025-06-30	$4,390,475	13,464	+109.3%	Shares	Sole	2025-08-14
2025-03-31	$1,736,768	6,432	+41.2%	Shares	Sole	2025-05-12
2024-12-31	$1,072,072	4,556	+35.4%	Shares	Sole	2025-02-14
2024-09-30	$925,750	3,366	+50.3%	Shares	Sole	2024-11-14
2024-06-30	$544,320	2,240	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.